Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.

log into MY ENETS

ENETS Abstract Search

#1000 E.L.I.O.S. (Educational Learning Investigational Observational Study): An Initial Update on Neuroendocrine Tumors (NETs) in the Southern Italy

Introduction: Elios is an Educational Learning Investigational Observational Study.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Tafuto S

Authors: Tafuto S, Faggiano A, Riccardi N, Palmieri G, Tatangelo F,

Keywords: neuroendocrine tumor, epidemiology, ssa ,

#963 From E.L.I.O.S. (Educational Learning Investigational Observational Study) an Initial Update on Neuroendocrine Tumors (NETs) in the Southern Italy

Introduction: Elios is an Educational Learning Investigational Observational Study.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Tafuto S

Authors: Tafuto S, Faggiano A, Riccardi N, Palmieri G, Tatangelo F,

Keywords: neuroendocrine tumor, epidemiology, SSA,

#735 Efficacy of Somatostatin Analogues (SSAs) in Patients with Neuroendocrine Tumors (NETs) According to the 2010 WHO Classification of NET: A Multicentric Study

Introduction: SSAs have recently been demonstrated to have antiproliferative effects in ileal NETs. No data are available on SSA efficacy according to 2010 WHO NET categories.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Faggiano A, Tafuto S, Riccardi F, Tozzi L, Belfiore A,

Keywords: neuroendocrine tumor, Somatostatin Analogues, efficacy, WHO classification,

#51 Epidemiology of the neuroendocrine tumors diagnosed in Cardarelli Hospital: a retrospective single-institution analysis of 274 cases

Introduction: Neuroendocrine tumors (NETs) are considered rare tumors and are characterized by their ability to produce peptides that cause typical hormonal syndromes. Neuroendocrine tumors consist of a wide spectrum of malignancies with different histology that can arise from distributed neuroendocrine cells in the body. Although these tumors are frequently indolent, they can be aggressive and resistant to therapy. Its incidence in the U.S.A has been rising in the last three decades (Surveillance, Epidemiology, and End Results registry). NETs are more common than generally believed.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author: Riccardi F

Authors: Riccardi F, Nappi O, de Ruggiero I, Rizzo M, Monaco G,

Keywords: NET, neuroendocrine tumor, octreotide, predicting marker of response,